lumateperone 42 mg
Price range: $60.00 through $450.00
| Quantity Value | Price | Quantity | Add To Cart |
|---|---|---|---|
| 100 Capsules | $110.00 |
|
|
| 200 Capsules | $200.00 |
|
|
| 50 Capsules | $60.00 |
|
|
| 500 Capsules | $450.00 |
|
SKU : N/A
Category : Psychiatric Medicine
Lumateperone 42 mg is an atypical antipsychotic medication containing lumateperone, used under medical supervision to treat schizophrenia, bipolar depression, and as adjunctive therapy in major depressive disorder.
Product Overview
Lumateperone 42 mg is an atypical antipsychotic medicine formulated for oral use, indicated for the treatment of certain serious mental health conditions in adults. It belongs to a class of compounds that modulate key neurotransmitter systems involved in mood, thought, and behavior. This medicine is primarily used under medical supervision to help improve symptoms associated with schizophrenia, depressive episodes in bipolar disorder, and as an adjunctive treatment for major depressive disorder (MDD) when combined with antidepressants. Lumateperone has a distinct pharmacological profile designed to offer therapeutic benefits while minimizing some of the side effects commonly seen with other antipsychotics.
How It Works
Lumateperone 42 mg acts on multiple neurotransmitter pathways in the brain, particularly serotonin, dopamine, and glutamate systems. Its mechanism of action is not completely defined, but current evidence suggests it functions as a potent antagonist at central serotonin 5‑HT₂A receptors and exhibits partial agonist and antagonist activity at dopamine D₂ receptors. This dual modulation helps regulate the balance of dopamine and serotonin neurotransmission, which are critical in mood regulation and psychotic symptom control. Additionally, lumateperone indirectly influences glutamatergic transmission, contributing to its therapeutic effects on cognitive and mood symptoms. Its activity at these receptor systems may help reduce positive symptoms such as hallucinations and delusions in schizophrenia and improve mood symptoms in depressive disorders while potentially lowering the risk of certain motor side effects associated with traditional antipsychotics.
Uses / Indications
Lumateperone 42 mg is indicated in adult patients for:
-
Schizophrenia – for the treatment of acute and chronic symptoms in adults.
-
Bipolar I or II Depression – for depressive episodes, either alone (monotherapy) or combined with mood stabilizers such as lithium or valproate.
-
Major Depressive Disorder (MDD) – as an adjunctive therapy to standard antidepressants in adults who continue to have depressive symptoms.
These indications are based on clinical trials and regulatory approvals that demonstrate efficacy in targeted populations when administered under a healthcare provider’s guidance.
Composition
Each capsule of lumateperone 42 mg contains 42 mg of the active pharmaceutical ingredient lumateperone (equivalent to a lumateperone tosylate salt). The formulation is designed for once‑daily use and may include inactive excipients that facilitate absorption and stability but do not contribute to the therapeutic effect. Lumateperone is classified pharmacologically as an atypical antipsychotic with a unique multimodal mechanism.
Administration
Lumateperone 42 mg is taken orally, typically once daily, with or without food, as directed by a qualified healthcare provider. The medicine is usually administered at a consistent time each day to maintain stable blood levels. Because of its effects on the central nervous system, lumateperone should only be started and adjusted under medical supervision. Patients should not alter their dose or discontinue use without consulting a clinician, especially if they are using other psychotropic medications.
Storage Instructions
Store lumateperone capsules in a cool, dry place at room temperature, away from direct sunlight and moisture. Keep the medicine out of reach of children and pets. Do not use the product beyond the expiration date printed on the package, and properly dispose of any unused medicine following local guidelines or your pharmacist’s instructions.
Important Information / Warning
Use of Lumateperone 42 mg should always be guided by a qualified healthcare provider. It may cause side effects, including somnolence, sedation, fatigue, and gastrointestinal symptoms, which should be reported to a clinician if persistent or severe. Elderly patients with dementia‑related psychosis treated with antipsychotics may have an increased risk of mortality, and lumateperone has not been established as safe or effective in this population. Serious but rare reactions such as neuroleptic malignant syndrome or tardive dyskinesia can occur; immediate medical attention is necessary if symptoms such as severe muscle stiffness or uncontrolled movements develop. Monitor metabolic parameters, mood changes, and potential drug interactions while on treatment.
👉 External Resource: For complete prescribing information and patient guidance, see the U.S. FDA label for Caplyta (lumateperone) — https://www.accessdata.fda.gov.
| Pack Size |
100 Capsules ,200 Capsules ,50 Capsules ,500 Capsules |
|---|
